Wim Das

Wim Das is a seasoned entrepreneur and investor with extensive experience across various sectors including biotechnology, real estate, and dental care. As the owner of XYZ BV and a shareholder in multiple organizations, including Aminoverse B.V. and ArthroSave B.V., Wim Das has demonstrated a commitment to innovative solutions, particularly in enzyme development and medical device technology. With a strong background in biotech investment as a managing partner at Forbion and significant contributions to the expansion of PrimeDentalAlliance, Wim Das has played a crucial role in driving growth and operational success. Additionally, Wim Das serves on the supervisory board of MCB International, further showcasing expertise in strategic guidance and corporate governance. An alumnus of Tilburg University with a degree in Business Administration and a postdoctoral qualification in Accountancy, Wim Das combines academic excellence with practical leadership experience.